|drug1722||Ivermectin oral Wiki||1.00|
|drug4022||standard care Wiki||0.50|
|D013313||Stress Disorders, Post-Traumatic NIH||0.19|
|D016638||Critical Illness NIH||0.13|
There is one clinical trial.
The global escalation of COVID19 pandemic has put the health care system under pressure with urgent need for treatment. In the absence of vaccine and approved drug against SARS-COV2 over the past 6 months, the health authorities were obliged to re-purpose existing drugs to fight this pandemic.
Description: Negative PCR result of SARS-Cov2 RNA in COVID19 patientsMeasure: PCR of SARS-Cov2 RNA Time: 14 days
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports